Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
about
Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionThe oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention"A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian CancerFull-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis.A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges.Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours.Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping reviewUnderestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study.Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsA cost analysis of a cancer genetic service model in the UKAre physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.Genetic risk and gynecologic cancers.Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.The dire need to develop a clinically validated screening method for the detection of early-stage ovarian cancer.Ovarian Cancer Prevention, Screening, and Early Detection: Report From the 11th Biennial Ovarian Cancer Research Symposium.Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features.Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.
P2860
Q26744525-FCA5231A-C2A6-471A-A71D-B7415270F1DBQ27025315-5D51E842-26DB-463E-91A1-8C90567BBB93Q33606561-5D5EEACB-A56F-4B71-BBCB-C4973621E283Q34288968-C769EEB6-2C92-4DB9-9E5F-1B6A57B82E69Q34409715-E7B9F2DC-79DD-4933-9A93-432112BCBE1AQ34856782-9AF81402-F760-4058-9561-13583DE233BCQ35739542-2F23F94F-F033-4B34-9CBD-0E34D7E964AAQ36108520-D5E24938-69E2-4EA8-98FA-D5D49408E4E3Q36304418-ACEE6D08-1A1E-475A-8238-37A3EA0BD993Q36925152-2E2303CD-CCA9-43ED-B648-110F982AB66AQ37089636-B9F7A055-0755-4F43-937A-2F04084490D8Q37124110-B120C3DD-3CD1-4693-950F-6122037EC229Q37227896-8C45A3AA-7DD5-4791-B85D-1594E7B8347DQ37468316-C5EA1279-03E7-4B7C-89E6-017C5A74C4F4Q37507366-421195EB-8B74-4D4F-BDE5-4A9F92FB878FQ38609944-FDC57B0D-D18F-4211-BDF5-874FD293340DQ38727225-0F231E4E-1AE8-49FE-8358-D09A1D445860Q43021437-70DF9C61-D600-44F7-A5B8-03F2E2BB7EF2Q47185178-24AF0BFB-E221-4C78-88D4-B68CF023498EQ48110433-EA0261C1-F982-49EA-97B0-7A993BA6C754Q49909339-0AE5F757-AEBD-4D4F-9BB7-FA64B28E9BD9Q50091589-3254FF77-E63D-41E7-A82E-6338D1D5D45BQ50195463-984E1328-52A2-4A7D-8E09-38EB5AD5AD12
P2860
Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
@en
Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
@nl
type
label
Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
@en
Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
@nl
prefLabel
Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
@en
Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
@nl
P2093
P356
P1476
Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
@en
P2093
Charlotte C Sun
Janice S Kwon
Karen H Lu
P304
P356
10.1200/JCO.2008.21.4684
P407
P577
2009-10-19T00:00:00Z